Prevention of bacterial meningitis: An overview of Cochrane systematic reviews

Respiratory Medicine

Volumn 101, Issue 10, 2007, Pages 2037-2043

  Prasad, Kameshwar ^a   Karlupia, Neha ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Meningitis; Prevention; Systematic review

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CIPROFLOXACIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; MINOCYCLINE; PENICILLIN G; PLACEBO; POLYSACCHARIDE VACCINE; RIFAMPICIN;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL MENINGITIS; CHEMOPROPHYLAXIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COCHRANE LIBRARY; CRYING; DISEASE TRANSMISSION; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EPIDEMIC MENINGITIS; EVIDENCE BASED MEDICINE; FEVER; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNOGENICITY; INFECTION RISK; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; IRRITABILITY; LIQUORRHEA; MENINGOCOCCOSIS; META ANALYSIS; MORTALITY; NEISSERIA MENINGITIDIS; NEUROPROTECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SEPTICEMIA; SIDE EFFECT; SINGLE DRUG DOSE; SKULL BASE FRACTURE; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VACCINATION;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CIPROFLOXACIN; FEMALE; HUMANS; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP A; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 34548299913     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.06.030     Document Type: Review

References (28)

1. Van de Beek D., Schmand B., De Gans J., et al. Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 186 (2002) 1047-1052
2. Patel M, Lee CK, Polysaccharide vaccines for preventing serogroup A meningococcal meningitis; Cochrane Database of Systematic Reviews 2005; (1).
3. Conterno LO, Silva Filho CR, Ruggeberg JU, Heath PT. Conjugate vaccines for preventing meningococcal C meningitis and septicaemia. Cochrane Database of Systematic Reviews 2006; (3).
4. Swingler G, Fransman D, Hussey G. Conjugate vaccines for preventing Haemophilus influenzae type B infections. Cochrane Database of Systematic Reviews 2003; (4).
5. Fraser A, Gafter-Gvill A, Paul M, Leibovici L. Antibiotics for preventing meningococcal infections. Cochrane Database of Systematic Reviews 2005; (1).
6. Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures. Cochrane Database of Systematic Reviews 2006; (1).
7. Maiden M.J.C., and Caugant D.A. The population biology of Neisseria meningitidis: implications for meningococcal disease, epidemiology and control. In: Frosch M., and Maiden M.C.J. (Eds). Handbook of meningococcal disease: infection biology, vaccination, clinical management (2006), Wiley-VCH, Chichester
8. van Deuren, Brandtzaeg P., and van der Meer J.W.M. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13 (2000) 144-166
9. IFRC, MSF, UNICEF, WHO Appeal for Meningococcal Meningitis Control in Countries at Risk in the African Continent, 1997-2000. Global Meningococcal Disease Update: www.who.int/emc/diseases/meningitisor, www.who.int/vaccines-diseases/meningitis_distr.htm. 1997 (last accessed 12 June 2007).
10. Ebrahim G.J. Meningococcal meningitis. J Trop Pediatr 43 (1997) 126-127
11. Snape M., and Pollard A. Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect Dis 5 (2005) 21-30
12. Goldschneider I., Gotschliche E.C., and Malcolm S. Artenstein. Human immunity to the meningococcus. The role of humoral antibodies. J Exp Med 129 (1969) 1307-1326
13. Suker J., and Feavers I.M. Prospects offered by genome studies for combating meningococcal disease by vaccination. Fut Med 2 (2001) 273-283
14. White M. Heath preventative strategies on meningococcal disease. Arch Dis Child 76 (1997) 178-181
15. Gold R., Lenow M.L., Goldschneider I., Draper T.L., and Gotschich E.C. Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. J Clin Invest 56 (1975) 1536-1547
16. Taunay A.E., Galvao J.S., de Morais E.C., and Gotschlich E.C. Disease prevention by meningococcal serogroup C polysaccharide vaccine in pre-school children: results after eleven months in Sao Paulo, Brazil abstract. Pediatr Res 8 (1974) 429
17. Farrington C P. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 22 (1993) 742-746
18. Hatton P. The use of the screening technique as a method of rapidly estimating vaccine efficacy. Publ Health 104 (1990) 21-25
19. Pollard A.J. Meningococcal disease and healthcare workers: the risks to healthcare workers are very low. BMJ 319 (1999) 1147-1148
20. Katzen JT, Jarrahy R, Eby JB, Mathiasen RA, Margulies DR, Shahinian HK. Craniofacial and skull base trauma. Available at: www.skullbaseinstitute.com (last accessed 12 June 2007).
21. Daoud A.S., Al-Sheyyab M., Batchoun R.G., Rawashdeh M.O., Nussair M.M., and Pugh R.N.H. Bacterial meningitis: still a cause of high mortality and severe neurological morbidity in childhood. J Trop Pediatr 41 (1995) 308-310
22. Bucher H.C., Kunz R., Cook D., Holbrook A., and Guyatt G. Therapy and applying the results of surrogate outcomes. In: Guyatt G., and Rennie D. (Eds). Users' guides to the medical literature: a manual for evidence-based clinical practice (2002), American Medical Association, Chicago
23. Joseph H., Ryall R., Bybel M., et al. Immunogenecity and immunological priming of serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2 year old children. J Infect Dis 1 (2003) 1142-1146
24. Schuchat A., robinson K., Wenger J.D., Harrison L.H., Farley M., and Reingold A.L. Bacterial meningitis in the United States in 1995: active survellience team. N Engl J Med 337 (1997) 970-976
25. W.H.O. State of the world's vaccines and immunization, revised edn. World Health Organization; 2003.
26. Anonymous. The evolving vaccine pipeline; www.who.int/entity/immunization_delivery/new_vaccines/Evolving-vaccine-p ipeline.pdf (last accessed 12 June 2007).
27. Rosenstein N.E., Perkins B.A., Stephens D.S., Popovic T., and Hughes J.M. Meningococcal disease. N Engl J Med 344 (2001) 1378-1388
28. Sáfadi M.A.P., and Barros A.P. Meningococcal conjugate vaccines: efficacy and new combinations. J Pediatr (Rio J) 82 (2006) S35-S44